Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2

Blood

Volumn 92, Issue 6, 1998, Pages 2118-2122

  Liang, Jian ^b   Prouty, Leonard ^b   Williams, B Jill ^b   Dayton, Mark A ^b   Blanchard, Kerry L ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 8; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE TRANSLOCATION; HUMAN; LEUKEMIA; PHAGOCYTOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION;

EID: 0032530267     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.6.2118.418k09_2118_2122     Document Type: Article

References (23)

1. Mrozek K, Heinonen K, de la Chapelle A, Bloomfield CD: Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 24:17, 1997
2. Caligiuri MA, Strout MR Gilliland DG: Molecular biology of acute myeloid leukemia. Semin Oncol 24:32, 1997
3. Croce CM, Nowell PC: Molecular genetics of human B cell neoplasia. Adv Immunol 38:245, 1986
4. Thandla S, Aplan PD: Molecular biology of acute lymphocytic leukemia. Semin Oncol 24:45, 1997
5. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR-α with a novel putative transcription factor, PML. Cell 66:663, 1991
6. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RAR-α fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
7. Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, Stone RM: A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): Description of a distinctive clinicopathologic entity [see comments]. Blood 85:1881, 1995
8. Still IH, Chernova O, Hurd D, Stone RM, Cowell JK: Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: Evidence for three discrete loci involved in myeloid leukemias on 8p11. Blood 90:3136, 1997
9. Aguiar RC, Chase A, Coulthard S, Macdonald DH, Carapeti M, Reiter A, Sohal J, Lennard A, Goldman JM, Cross NC: Abnormalities of chromosome band 8p11 in leukemia: Two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood 90:3130, 1997
10. Borrow J, Stanton VP Jr, Andresen JM, Becher R, Behm FG, Chaganti RS, Civin CI, Disteche C, Dube I, Frischauf AM, Horsman D, Mitelman F, Volinia S, Watmore AE, Housman DE: The translocation t(8; 16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyItransferase to the CREB-binding protein [see comments]. Nat Genet 14:33, 1996
11. Macdonald D, Aguiar RC, Mason PJ, Goldman JM, Cross NC: A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: A review [see comments]. Leukemia 9:1628, 1995
12. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA: FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukemia/lymphoma syndrome. Nat Genet 18:84, 1998
13. Carapeti M, Aguiar RCT, Goldman JM, Cross NCP: A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in AML with the inv(8)(p11q13). Blood 90:318a, 1997 (abstr, suppl 1)
14. Lai JL, Zandecki M, Fenaux P, Preudhomme C, Facon T, Deminatti M: Acute monocytic leukemia with (8;22)(p11;q13) translocation. Involvement of 8p11 as in classical t(8;16)(p11;p13). Cancer Genet Cytogenet 60:180, 1992
15. Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S, Shaft D, Kodman Y, Gobuzov R, Ash S, Stein J, Yaniv I, Barak Y, Zaivov R: A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8;16)(p11;p13), in a patient with the variant t(8;19)(p11; q13) - Case report and review of the literature. Leuk Res 19:367, 1995
16. Reifsnyder C, Lowell J, Clarke A, Pillus L: Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases [see comments]. Nat Genet 14:42, 1996 (erratum 16:109, 1997)
17. Reifsnyder C, Lowell J, Clarke A, Pillus L: Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases [see comments]. Nat Genet 14:42, 1996 (erratum 16:109, 1997)
18. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegel-berger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ: MLL is fused to CBP, a histone acety Itransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 94:8732, 1997
19. Bannister AJ, Kouzarides T: The CBP co-activator is a histone acetyltransferase. Nature 384:641, 1996
20. Ogryzko W, Schiltz RL, Russanova V, Howard BH, Nakatani Y: The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953, 1996
21. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H: TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667, 1996
22. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H: The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J 17:507, 1998
23. Brownell JE, Allis CD: Special HATs for special occasions: Linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6:176, 1996